Presage Biosciences (anti-cancer drug candidate voruciclib) is Buildings and Property in United States that focus on cyclin-dependent kinase business. They cover business area such as (CDK) inhibitor, oncology treatment, mechanism, drug resistance, patient outcome.
-
Cyclin-dependent Kinase
-
530 Fairview Avenue North
Suite 1000
Seattle, WA 98109
United States
Private
(CDK) inhibitoroncology treatmentmechanismdrug resistancepatient outcome
* We use standard office opening hours in near Presage Biosciences (anti-cancer drug candidate voruciclib)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Presage Biosciences (anti-cancer Drug Candidate Voruciclib) is Buildings and Property business from United States that founded in - ( years old in ), Presage Biosciences (anti-cancer drug candidate voruciclib) business is focusing on Cyclin-dependent Kinase.
Presage Biosciences (anti-cancer drug candidate voruciclib) headquarter office and corporate office address is located in 530 Fairview Avenue North Suite 1000 Seattle, WA 98109 United States.
Presage Biosciences (anti-cancer drug candidate voruciclib) was founded in United States.
In , Presage Biosciences (anti-cancer drug candidate voruciclib) is currently focus on cyclin-dependent kinase sector.
Above is snippet of Google Trends for "cyclin-dependent kinase" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Presage Biosciences (anti-cancer drug candidate voruciclib), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
